Publication | Open Access
Exosomal glypican-1 is elevated in pancreatic cancer precursors and can signal genetic predisposition in the absence of endoscopic ultrasound abnormalities
11
Citations
33
References
2022
Year
GPC1<sup>+</sup> crExos may act as biomarker to support the diagnosis and stratification of PDAC precursor lesions, and in signaling individuals with genetic predisposition in the absence of EUS abnormalities.
| Year | Citations | |
|---|---|---|
Page 1
Page 1